pubrio
Polfa Tarchomin S.A.

Polfa Tarchomin S.A.

Poland · Pharmaceuticals

Research

Pharmaceuticals

Health Care & Medical

Polfa Tarchomin S.A. in Warsaw is one of the largest generic companies operating in Poland and one of the oldest pharmaceutical producers in the world. The company history dates back to 1823 and the production of the first medicinal preparations. Polfa Tarchomin SA is a leader in the anti-infectives market. The company also holds an significant market position in the category of insulin, psychotropic drugs and dermatological preparations. Polfa Tarchomin S.A in total provides over a hundred medicinal products. All of them are available in a range of forms and sizes in order to ensure optimal medical treatment and minimal side effects experienced by the patient. Polfa Tarchomin S.A. specialises in the prescription drugs. Over the counter medicines constitute a supplement to the main product range. Our medicines are produced in buildings and facilities which meet strict global requirements and quality standards. The quality of our products has been confirmed by the obtained GMP certificates. Currently the company has 40 production lines and installations which produce drugs in pharmaceutical forms including gels, aerosols, tablets, coated tablets, capsules, ampoules, vials and insulin cartridges. The production line of oral penicillin forms, aerosol filling and freeze-drying techniques distinguish the company among other manufacturers in the industry.

Company Insights
Company Overview

1823

Founded

Pharmaceuticals

Industry

Poland

Location

11,897,486

Ranking

500 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Polfa Tarchomin S.A.

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​